Serum Albumin as a Prognostic Marker for Serious Non-AIDS Endpoints in the Strategic Timing of Antiretroviral Treatment (START) Study-Reference-Cited by-同舟云学术

Serum Albumin as a Prognostic Marker for Serious Non-AIDS Endpoints in the Strategic Timing of Antiretroviral Treatment (START) Study

Author:

Ronit Andreas¹,Sharma Shweta²,Baker Jason V³,Mngqibisa Rosie⁴,Delory Tristan⁵,Caldeira Luis⁶,Ndembi Nicaise⁷,Lundgren Jens D⁸,Phillips Andrew N⁹,

Affiliation:

1. Department of Infectious Diseases, Rigshospitalet, University of Copenhagen, Denmark

2. Division of Biostatistics, School of Public Health, University of Minnesota

3. Infectious Diseases and Department of Medicine, Hennepin County Medical Center, Minneapolis, Minnesota

4. Enhancing Care Foundation, Durban University of Technology, South Africa

5. Department of Infectious Diseases, Hospital Saint Louis, Assistance Publique–Hôpitaux de Paris, France

6. Clínica Universitária de Doenças Infecciosas, Faculty of Medicine, Santa Maria University Hospital, University of Lisbon, Portugal

7. Institute of Human Virology Nigeria, Abuja

8. CHIP, Department of Infectious Diseases, Rigshospitalet, University of Copenhagen, Denmark

9. Research Department of Infection and Population Health, University College London Medical School, United Kingdom

Funder

National Institutes of Health

National Cancer Institute

National Institute of Allergy and Infectious Diseases

National Institute of Arthritis and Musculoskeletal and Skin Diseases

Eunice Kennedy Shriver National Institute of Child Health and Human Development

National Institute of Child Health and Human Development

National Institute of Mental Health

National Institute of Neurological Disorders and Stroke

Publisher

Oxford University Press (OUP)

Subject

Infectious Diseases,Immunology and Allergy

Link

Reference34 articles.

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献